Global Innovation Index 2020: Switzerland is the world’s most-innovative country, but who will finance innovation?

Wednesday, September 2, 2020 @ 12:00 am

The 2020 edition of the GII ranks the innovation performance of 131 economies around the world relying on around 80 indicators. These indicators capture the institutional environment for innovation, the education system, research and development activity, the infrastructure for innovation and different forms of knowledge, technology and creative outputs.

The World Intellectual Property Organization released the Global Innovation Index (GII) 2020. As the world is struggling to cope with the implications of the COVID-19 crisis, there is a true risk that innovation expenditures and the means to finance entrepreneurial ventures will spiral downwards as global economic output declines. The impact of this shortage in innovation finance will be uneven, with the negative effects felt more heavily by young firms, by R&D-intensive firms, and start-ups in developing economies.

According to the GII 2020 innovation ranking, Switzerland is the world’s most-innovative country followed by Sweden, the United States of America, the United Kingdom, and the Netherlands.

Key Findings of the GII 2020 - Watch the 5 minute video and read the Global Innovation Index Report 2020

You may also be interested in

Life Science Cares launches in Switzerland

First international chapter of Life Science Cares established in Switzerland – bringing hearts and minds together by empowering the life sciences industry to support local communities.
April 19, 2024

ten23 health and Ypsomed collaborate on the commercialization of patch injector

ten23 health and Ypsomed today announced that they are entering into a strategic partnership to advance the commercialization of the YpsoDose wearable injector for subcutaneous self-injection of large-volume doses.
April 16, 2024

Orio Therapeutics raises CHF 500,000 for cardioprotective therapy development

Orio Therapeutics secures CHF 500,000 pre-seed funding to fuel the development of cardioprotective therapy for heart attack patients.
April 4, 2024

Newron valuation report "A pivotal year"

March 26, 2024

Stämm scales adherent cells by leveraging 3D printing and microfluidics

March 25, 2024

ten23 health: Partnership with SHL Medical

ten23 health, a leading Swiss Contract Development and Manufacturing Organization (CDMO) for sterile drugs, and SHL Medical, a world-leading provider of drug delivery devices, today announced their strategic partnership to provide a streamlined offering for pharmaceutical and biotech companies that require sterile drug/device combination products.
March 25, 2024